These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. beta-Glucosidase inhibition in murine peritoneal macrophages by conduritol-B-epoxide: an in vitro model of the Gaucher cell. Newburg DS; Yatziv S; McCluer RH; Raghavan S Biochim Biophys Acta; 1986 Jun; 877(1):121-6. PubMed ID: 3087427 [TBL] [Abstract][Full Text] [Related]
45. Gaucher disease in mice induced by conduritol-B-epoxide: morphologic features. Adachi M; Volk BW Arch Pathol Lab Med; 1977 May; 101(5):255-9. PubMed ID: 576797 [TBL] [Abstract][Full Text] [Related]
46. New perspectives in type 2 Gaucher disease. Sidransky E Adv Pediatr; 1997; 44():73-107. PubMed ID: 9265968 [No Abstract] [Full Text] [Related]
47. Measurement of lysosomal glucocerebrosidase activity in mouse liver using a fluorescence-activated cell sorter assay. Chan KW; Waire J; Simons B; Karey K; Fung J; Copeland D; Andrews L Anal Biochem; 2004 Nov; 334(2):227-33. PubMed ID: 15494128 [TBL] [Abstract][Full Text] [Related]
48. N-Alkylated aziridines are easily-prepared, potent, specific and cell-permeable covalent inhibitors of human β-glucocerebrosidase. Adams BT; Niccoli S; Chowdhury MA; Esarik AN; Lees SJ; Rempel BP; Phenix CP Chem Commun (Camb); 2015 Jul; 51(57):11390-3. PubMed ID: 26085065 [TBL] [Abstract][Full Text] [Related]
49. Liposomes in Gaucher type I disease: use in enzyme therapy and the creation of an animal model. Gregoriadis G; Weereratne H; Blair H; Bull GM Prog Clin Biol Res; 1982; 95():681-701. PubMed ID: 6812092 [No Abstract] [Full Text] [Related]